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Abstract In multiple sclerosis (MS), the combination of
visual, somatosensory and motor evoked potentials (EP)
has been shown to be highly correlated with the Expanded
Disability Severity Scale (EDSS) and to predict the disease
course. In the present study, we explored whether the
significance of the visual EP (VEP) can be improved with
multichannel recordings (204 electrodes) and topographic
analysis (tVEP). VEPs were analyzed in 83 MS patients
(median EDSS 2.0; 52 % with history of optic neuritis;
hON) and 47 healthy controls (HC). TVEP components
were automatically defined on the basis of spatial similarity
between the scalp potential fields (topographic maps) of
single subjects’ VEPs and reference maps generated from
HC. Non-ambiguous measures of latency, amplitude and
configuration were derived from the maps reflecting the
P100 component. TVEP was compared to conventional
analysis (cVEP) with respect to reliability in HC, validity
using descriptors of logistic regression models, and sensi-
tivity derived from receiver operating characteristics
curves. In tVEP, reliability tended to be higher for mea-
surement of amplitude (p = 0.06). Regression models on
diagnosis (MS vs. HC) and hON were more favorable
using tVEP- versus cVEP-predictors. Sensitivity was
increased in tVEP versus cVEP: 72 % versus 60 % for
diagnosis, and 88 % versus 77 % for hON. The advantage
of tVEP was most pronounced in pathological VEPs, in
which cVEPs were often ambiguous. TVEP is a reliable,
valid, and sensitive method of objectively quantifying
pathological VEP in particular. In combination with other
EP modalities, tVEP may improve the monitoring of dis-
ease course in MS.
Keywords Multiple sclerosis  Visual evoked
potentials  Topographic analysis  Quantification 
Surrogate marker
Introduction
Prolongation of the P100 latency of the visual evoked
potential (VEP) has long been used to detect subclinical
demyelinating lesions in multiple sclerosis (MS) localized
in the pre- and retro-chiasmal part of the visual pathway
through the use of full-field and hemi-field stimulation,
respectively (Halliday et al. 1972; Tobimatsu and Celesia
2006). Although no longer explicitly mentioned in the
latest revision of the diagnostic criteria for MS (Polman
et al. 2011), pathological VEP can provide proof of lesion
dissemination in space (Polman et al. 2005; McDonald
et al. 2001). Apart from diagnosis, the combination of VEP
with motor and somatosensory EP (i.e. multimodal EP) has
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been shown to be useful for disease monitoring and for
defining the long-term prognosis of MS both retrospec-
tively and prospectively (Fuhr et al. 2001; Kallmann et al.
2006; Invernizzi et al. 2011; Schlaeger et al. 2012a, b,
2013).
In order to increase the sensitivity of VEP for subclinical
involvement of the optic nerve in MS, a main focus of
research lies on advanced stimulation techniques. VEP to
low-contrast stimulation have shown more abnormalities
than high-contrast stimulation (Kupersmith et al. 1984;
Thurtell et al. 2009), and multifocal VEP were reported to
detect small or peripheral deficits more sensitively in ON
and opposite eyes (Klistorner et al. 2008, 2009; Laron et al.
2009). Furthermore, these two techniques have been
recently combined in a pilot study (Frohman et al. 2012).
However, the most common way to elicit a robust VEP is
still high-contrast full-field pattern stimulation.
For the purpose of disease monitoring, it is also
important to quantify pathological VEP with low ampli-
tudes: this may be problematic, particularly with conven-
tional readings. In the present study, we focus on an
approach to defining the VEP components independently of
amplitude.
Topographic analysis of multichannel evoked potential
recordings allows the objective analysis of EPs by defining
EP-components based on the spatial distribution of the
scalp potential field (i.e. the topographic map) rather than
the peak amplitude at a given electrode (Lehmann and
Skrandies 1984; Brandeis and Lehmann, 1986; Michel
et al. 2001; Murray et al. 2008; Michel and Murray, 2012).
In MS, topographic methods have been applied in one
small precursor study, in which analysis of 44 healthy
controls, 26 MS-patients and 20 patients with other neu-
rological diseases revealed a higher diagnostic sensitivity
(72 %) and specificity (100 %) of topographic analysis of
VEP (tVEP) compared to conventional waveform analysis
(Lascano et al. 2009). In that study, component definition
relied on the magnitude of spatial correlation between the
measured scalp potential field (i.e. the topographic map) at
single time points and reference topographic maps for EP-
components derived from a control group. In contrast,
conventional analysis depends on the subjective visual
identification of the P100 peak at predefined electrodes,
and the determination of latency and amplitude at this
peak.
In view of the promising results of the report by Lascano
et al. (2009), we tested in a larger sample of well-charac-
terized MS patients whether topographic analysis indeed
characterizes the P100-component more reliably than
conventional readings, especially in pathological VEP. We
first determined the reliability of the two methods in a
sample of healthy controls measured at baseline and after
1 year. Second, we assessed validity by exploring whether
topographic information is useful in distinguishing patients
from healthy controls and in detecting prechiasmal demy-
elination defined as a history of optic neuritis (ON). Third,
we determined sensitivity and specificity for diagnosis and
detection of a history of ON.
Materials and Methods
Subjects
The study was approved by the local ethics committee, and
all participants gave written informed consent before
inclusion. The baseline sample consisted of 83 MS patients
(median age 38.5 years; 80 % female; median Expanded
Disability Status Scale (EDSS, Kurtzke 1983) 2.0, range
0–5.5; median disease duration 9.2 years, range
0.3–30.8 years) diagnosed with clinical isolated syndrome
(n = 5; 6.0 %), relapsing-remitting MS (n = 76; 91.6 %)
and secondary progressive MS (n = 2; 2.4 %) according to
Polman et al. (2005). History of optic neuritis (hON) was
defined retrospectively by chart review. Clinical standard
criteria were used to make the diagnosis: unilateral decline
or loss of vision over a period of hours or a few days, pain
on eye movement, and decreased perception of color
(Balcer 2006). Forty-three patients (52 %) had a positive
history of ON. In 28 patients, ON was the first symptom; 19
patients had more than one episode of ON; in three
patients, ON had taken place eleven or twelve months prior
to the baseline exam. In the hON-group, visual acuity as
determined with a Snellen chart was less than 0.8 in 17
eyes of 13 subjects (mean visual acuity: 0.84, SD: 0.24); in
the non-hON-group, 5 eyes in 5 subjects had a visual acuity
less than 0.8 (mean visual acuity: 0.95, SD: 0.1). All MS
patients were examined at prescheduled visits outside a
clinical relapse, and at least 4 weeks after corticosteroid
treatment for a relapse had been tapered off.
Forty-seven subjects served as healthy controls (HC),
defined by an unremarkable personal history, a normal
short neurological exam and a corrected visual acuity of
0.8 or better in at least one eye (median age 38.0 years,
75 % female). Thirty-six of these were re-examined after
1 year.
VEP Recording
Visual EPs were recorded with a 256-channel EEG system
(Netstation 200 with HydroCel Geodesic Sensor Net,
Electrical Geodesics, Inc., Oregon, USA). The electrode
net was placed with Fz, Cz, Oz, and the preauricular points
as landmarks. Electrode impedances were kept below
40 kOhm. Recording band-pass was 0.1–100 Hz, sampling
frequency 1 kHz, and the vertex was used as the recording
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reference. Full-field checkerboard stimulation was applied
to each eye separately (central fixation; rectangular stim-
ulus field diagonally subtending 10.3 of visual angle;
check-size, 30.960 minutes of arc; 2 9 300 stimuli per eye;
526 ms interstimulus interval; mean luminance 57.5 cd;
Michelson contrast, 97 %) according to international
guidelines (Celesia and Brigell 1999). Raw data were
visually inspected, band-pass filtered (1–30 Hz) and aver-
aged excluding epochs with high amplitude artefacts.
Artefact-contaminated electrodes were interpolated using a
spherical spline algorithm (Perrin et al. 1989). For topo-
graphic analysis, 204 channels were used and re-referenced
to their average, leaving out electrodes at the cheeks and
the neck.
Conventional Analysis
Conventional analysis (cVEP) was performed indepen-
dently by two board-certified neurophysiologists who were
blinded to the subjects’ diagnosis. Latency and amplitude
(N75- to P100-peak) of the P100 were determined from the
waveform recorded at the Oz-Fpz electrode pair for each
eye. In 13 VEP, the two readers had differing opinions on
the P100 peak, and a consensus was reached.
Topographic Analysis
Topographic analysis was performed with the free aca-
demic software Cartool (Brunet et al. 2011), as has been
described previously (Murray et al. 2008; Lascano et al.
2009).
In contrast to conventional analysis, in which the dif-
ference between the electric potentials at two electrodes is
measured, topographic analysis relies on the distribution of
the electric potential at the scalp (i.e. the topographic map)
recorded from a multichannel electrode array. Instead of a
voltage time series that forms a waveform for each elec-
trode (Fig. 1a, b), the VEP is represented as a time series of
topographic maps, as shown in Fig. 1c for the grand mean
VEP of all healthy controls. The time series is character-
ized by time periods in which topographic maps have a
stable and distinct distribution of the electric potential
which varies only in intensity. These periods have been
called functional microstates (Lehmann and Skrandies
Fig. 1 Topographic analysis I: generation of reference maps from
healthy controls. a Conventional VEP (Oz–Fpz-electrode pair) from
the grand mean VEP of all healthy controls. b Butterfly plot of the
grand mean VEP of all healthy controls derived from 204 electrodes
(average reference). c Grand mean VEP represented as a time series
of topographic maps derived from the butterfly plot: time periods of
quasi-stable topographies (‘‘functional microstate’’) are flagged by
parentheses (for display, each five single topographic maps (=5 ms)
are averaged). d Reference maps of single EP-components; from left
to right, the ‘‘N75/N145’’-, ‘‘P100’’- and ‘‘P240’’-maps are displayed
and color-coded. Reference maps are the average of a group of
topographic maps with high spatial similarity; N75 and N145 are
represented as one reference map because of their overlapping spatial
distribution of the electric potential on the scalp. e Butterfly plot as in
(b) with additional color-coding according to the presence of a
component during the time course of the EP, determined by the
magnitude of spatial similarity of single topographic maps with one of
the reference maps (fitting procedure, see text) (Color figure online)
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1984; Brandeis and Lehmann 1986; Michel et al. 2001;
Murray et al. 2008). Each microstate typically covers the
period of a peak in the evoked potential waveform, i.e.
what is traditionally called an evoked potential component.
In order to objectively determine the mean topographic
map of these components, a k-means cluster analysis can be
applied that clusters together all single topographic maps
with similar spatial distribution of the potential field
regardless of their chronological order. The optimal number
of clusters is determined by a cross-validation criterion
(Pascual-Marqui et al. 1995; Murray et al. 2008). In our data,
this analysis found three cluster maps to be optimal for
representation of the traditional EP-components of the
grand-mean VEP (Fig. 1d). The cluster algorithm did not
distinguish between the N75 and N145 components, as the
single topographic maps in the time windows 50–87 ms and
135–180 ms were spatially very similar; therefore, they are
represented as a single mean topographic map. In order to
define the time at which each component is present, the
spatial correlation between the mean topographic maps and
each single topographic map of the time series is calculated.
Subsequently, each point in time is defined as belonging to
the component to which the magnitude of correlation is
highest. This fitting procedure revealed, as expected, that the
three mean topographic maps represent the periods tradi-
tionally labeled N75, P100, N145, and P240 (Fig. 1e). In
subsequent analysis, these mean topographic maps will be
used as reference maps and referred to as the ‘‘N75/N145’’-,
‘‘P100’’-, and ‘‘P240’’-maps (Fig. 1d).
Figure 2 displays the fitting procedure applied to an
individual VEP of a healthy subject. From the butterfly plot
(Fig. 2b) the individual time course of topographic maps is
derived (Fig. 2c), and each time point of the butterfly plot
is color-coded (Fig. 2e) according to the magnitude of the
spatial correlation of the corresponding topographic map to
one of the reference maps (Fig. 2d). In order to quantify the
field strength of the VEP at each time point, the global field
power (GFP) was used (Lehmann and Skrandies 1980).
GFP is defined as the standard deviation of the mean
amplitude over all electrodes at a single time point. Fig-
ure 3a shows in the same healthy subject as in Fig. 2 the
GFP time course (lower panel) derived from the butterfly
plot (middle panel) with corresponding color-coding.
Supplemental figures (Fig. S1 and S2) depict the fitting
procedure including the time series of topographic maps
for the two MS subjects shown in Fig. 3b, c.
For analysis, the following parameters were used from
the topographically defined P100 component: topographic
Fig. 2 Topographic analysis II: automatic definition of EP compo-
nents in an individual VEP. a Conventional VEP (Oz–Fpz-electrode
pair) in a healthy control. b Butterfly plot of same subject derived
from 204 electrodes (average reference). c VEP represented as a time
series of topographic maps derived from the butterfly plot. (For
display, five single topographic maps (=5 ms) are averaged). Marked
asymmetry is seen despite monocular full-field stimulation.
d Reference maps of single EP components derived from all healthy
controls (see Fig. 1d). e Butterfly plot as in (b) with additional color-
coding according to the presence of a component during the time
course of the EP, determined by the magnitude of spatial similarity of
single topographic maps with one of the reference maps (fitting
procedure, see text) (Color figure online)
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amplitude (tAmp) given as the maximal GFP, topographic
latency (tLat) given as the time point of maximal GFP,
‘‘configuration’’ (tFit) given as the maximal value of spatial
correlation to the reference map, and the mean amplitude
(tAUC) given as the total sum of GFP while the P100
component was present, corresponding to the area under
the component curve of the GFP time course (Fig. 3, lower
panel). In very pathological VEP, in which all single
topographic maps show a higher spatial correlation to the
‘‘N75/N145-’’ or ‘‘P240’’-map than to the ‘‘P100’’-map, the
fitting procedure only yields these components, but no
P100 component (Fig. 3c and Fig. S2). To include these
very pathological VEP in the statistical analysis, as well as
conventional VEP in which no P100 peak could be defined,
values were replaced by the most pathological measured
values of the sample, as described below.
The time window for detection of the P100 component
was restricted to 70–150 ms in order not to quantify late
components with a P100 topography and high GFP as P100
latency and P100 amplitude, despite a clear but lower peak
of the P100 component with normal latency, as shown for a
healthy control in Fig. 3a. Consequently, in MS cases with
very prolonged latencies, the true peak lies outside this
time window, and thus the end of the time window is
recognized as the peak of the P100 component (Fig. 3b and
Fig. S1).
Data Pre-processing
The distributions of all calculated values from conventional
and topographic analysis were tested for normality using
q–q-plots and a Kolmogorov–Smirnov-test, and log-trans-
formed when necessary. Control subjects were then used as
the reference sample for z-transformation, and the mean
z-value of each subject’s left and right VEP was used for
statistical analysis.
In order to analyze all subjects (n = 83 patients, n = 47
HC), it was necessary to replace the VEP values of eyes in
which no valid conventional or topographic P100 could be
determined. Three replacement procedures were employed.
In VEPs of eyes with pathology other than MS, or visual
acuity below 0.8 in control subjects, values were replaced
by the values of the VEP from the subject’s opposite eye
(procedure 1). In VEPs in which no P100 peak could be
Fig. 3 Examples of single VEPs in a healthy subject (a) and two
patients (b, c); upper panel: conventional VEP; middle panel:
butterfly plots with topographically defined, color-coded EP compo-
nents; lower panel: corresponding time course of GFP with respective
color-coding. (GFP global field power, uV microVolt; red lines: time
window for quantitative analysis). a Same healthy subjects as in
Fig. 2: in addition to conventional waveform and butterfly plot with
color-coded EP-components (see Fig. 2), the time course of the GFP
and the time window for analysis is shown (lower panel). A wider
time window would have falsely given the late peak as the latency of
the P100 component. b MS patient with positive history of ON, visual
acuity 0.5, EDSS 4.0: conventional waveform shows a small and a
high positive peak at 95 and 160 ms, latency and amplitude
measurement is ambiguous; the color-coding of the butterfly plot
and the time course of GFP reflect the fact that spatial similarity of
topographic maps (see Fig. S1) is highest to the ‘‘P100’’-reference; for
analysis, the latency at the end of the time window is used
(tLat = 150 ms; replacement procedure 3). c MS patient with
positive history of ON, visual acuity 0.5, EDSS 2.0: conventional
waveform shows a shallow peak at 103 ms; the color-coding of the
butterfly plot and the time course of GFP reflect the fact that spatial
similarity of topographic maps (see Fig. S2) is highest to the ‘‘N75’’-
reference; for analysis, the most pathological values of latency,
amplitude and configuration (tLat, tAmp, tAUC and tFit) measured in
the sample are used (replacement procedure 2) (Color figure online)
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visually determined or no P100 component could be
defined topographically (Fig. 3c and Fig. S2), the most
pathologically measured values of the sample were used
(procedure 2), as suggested previously (Fuhr et al. 2001;
Schlaeger et al. 2012b). The same replacements were done
in VEP from eyes with visual acuity of 0.2 or less due to
ON, as recordings may not be reliable because of poor
fixation. In tVEP, in which the true P100 peak lay outside
the predefined time window (Fig. 3b and Fig. S1), the end
of the time window (150 ms) was taken as the latency
(procedure 3); when the tVEP peak was at the very
beginning of the time window (\80 ms), it was also
replaced with the maximal topographic latency (150 ms) as
such a non-physiologic early peak was considered to reflect
severe pathology.
Table 1 gives the number of subjects and VEPs, reasons
for replacements, and replacement procedures. In topo-
graphic analysis, 31 VEPs in 25 patients were affected; 19
VEPs in 17 patients had to be replaced and 12 VEPs in 10
patients had the true peak outside or at the very beginning
of the pre-defined time window (two subjects are counted
twice because of a replacement in one eye and a peak
outside the time window in the other eye). In conventional
analysis, 14 VEPs in 12 patients were replaced. In the 2
VEPs from the 2 patients’ eyes with non-MS-pathology
(strabismic and congenital amblyopia), the values of the
same subject’s opposite eye were used. In 8 VEPs from 6
patients without discernible P100 peak and in the 4 VEPs
of the 4 patients’ eyes with visual acuity \=0.2, the most
pathological measured conventional values were used. In
healthy controls, 5 VEPs in 5 subjects (baseline) and 2
VEPs in 2 subjects (year 1) were replaced by the respective
conventional and topographic values of the same subject’s
opposite eye, as the visual acuity was less than 0.8 at the
replaced side because of an uncorrected refractive error.
To estimate the effect of replacements, sensitivity
analyses were performed in the 58 patients and 42 healthy
controls without replacements.
Statistics
The R-project software package (Version 2.12.1) and SPSS
(SPSS IBM Statistics, version 20.0) were used for statis-
tical analyses.
Test–Retest-Reliability
In healthy controls, the intraclass correlation coefficient
between corresponding baseline and year 1 values was
calculated for each conventional and topographic measure.
The standard deviation of the difference between baseline
and year 1 was used to describe variability and compared
between the two methods by Pitman’s test (Pitman 1939;
Howell 1997). Pitman’s test is based on the idea that, if
there is no significant difference between two methods,
there should be no significant correlation between the sum
and the difference of the differences between baseline and
year 1 measured with method A or method B.
Validity
In order to compare conventional and topographic measures
as predictors of diagnosis (MS vs. healthy control),
descriptors of logistic regression models (stepwise back-
wards procedure; log-likelihood-ratio; p in = 0.1, p out =
0.11) were used. Model comparisons were based on the
amount of explained variability adjusted for number of
predictors (adjusted pseudo-R2) and the Bayesian infor-
mation criterion (BIC). The BIC reduces the risk of over-
fitting by penalizing the complexity of the model, and thus is
a more meaningful model descriptor compared to the
adjusted pseudo-R2. The same analysis was repeated within
patients using ‘‘history of optic neuritis’’ instead of diag-
nosis as the dependent variable in the logistic regression.
Using the z-transformed values of the VEPs of the
subjects’ left and right eyes in mixed regression models
with the subject as random factor, instead of the mean
z-values of the VEPs of the two eyes, yielded similar
results to the described approach (data not shown). As
using the mean z-values of the VEPs of the two eyes is a
simpler way to account for the fact that the VEPs from a
subject’s left and right eye are not independent observa-
tions, this method was preferred.
Table 1 Number of MS-patients and VEPs with replacement of non-
valid values for topographic analysis (see text for conventional
analysis)
Subjectsa VEPs Reason Replacement by
2 2 Non-MS
pathologyb
tLat, tAmp, tAUC, tFit of
VEP of same subject’s
opposite eye
11
4
13
4
No P100
component
visual
acuity \= 0.2
Most pathological tLat, tAmp,
tAUC, tFit measured in the
samplec
9
1
11
1
True peak
outside time
window
non-
physiological
early peak
(79 ms)
tLat = end of time
window = 150 msc
a Two subjects are counted twice because different reasons for
replacements in VEP from right and left eye
b one strabismic, one congenital amblyopia
c see Fig. 3b, c
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Sensitivity and Specificity
Receiver operating characteristics (ROC) curves were
calculated for all models, and sensitivity and specificity
were determined at the cut-points of the ROC-curve which
maximizes the sum of sensitivity and specificity (index of
Youden YI).
Results
Reliability
In healthy controls, the intraclass correlation coefficient
between baseline- and year 1-values was highest for tLat
(r = 0.95) and cLat (r = 0.94), followed by tAmp
(r = 0.81), tAUC (r = 0.75), and cAmp (r = 0.73), and was
lowest for tFit (r = 0.67). The variability of longitudinal
change, expressed as its standard deviation (SD), showed no
significant difference between topographic and conventional
latency (tLat: mean change = -0.05, SD = 0.34; cLat:
mean change = -0.05, SD = 0.37; p = 0.095; absolute
mean change without z-transformation: tLat = 1.74 ms,
SD = 1.44; cLat = 1.72 ms, SD = 1.59), and there was
only a statistically insignificant trend toward lower vari-
ability (16 %) in topographic as compared to conventional
amplitude (tAmp: mean change = -0.10; SD = 0.57;
cAmp: mean change = -0.07, SD = 0.68; p = 0.059).
Validity
The explained variability, expressed as the adjusted pseudo-R2
and the Bayesian information criterion (BIC) as descriptors of
the logistic regression models, is shown in Table 2. The
models for the outcome diagnosis explained 28 % of the
variability (BIC: 130) with a combination of tLat (p\ 0.001)
and tFit (p\ 0.05), and 25 % (BIC: 131) with cLat
(p\ 0.001). The models for the outcome history of ON
explained 35 % of the variability (BIC: 82) with a combination
of tLat (p \0.001) and tAUC (p = 0.07), and 26 % (BIC: 91)
with a combination of cLat (p \0.01) and cAmp (p\ 0.05).
In the models on history of ON, the BIC was consistently
lower with topographic VEP measures than in the models with
conventional measures; this implies that the former had a
higher information content. When cases with replacements
were omitted in sensitivity analyses, conventional measures
had the lowest BIC; in the model on ‘‘diagnosis’’, cLat
(p\ 0.001) explained 14 % of the variability (BIC: 121) and a
combination of tLat (p \0.001 and tFit (p \0.05) explained
16 % of the variability (BIC: 123); in the model on ‘‘history of
ON’’, a combination of cLat (p\ 0.01) and cAmp (p\ 0.05)
explained 26 % of the variability (BIC: 64), and tLat
(p\ 0.001) explained 21 % of the variability (BIC: 65).
Sensitivity and Specificity
The sensitivity and specificity of conventional and topo-
graphic measures in predicting diagnosis and history of ON
at the point maximizing the index of Youden (YI) are given
in Table 3. Diagnosis was best predicted by a combination
of tLat and tFit, which was more sensitive but somewhat
less specific than the combination of cLat and cAmp
(sensitivity: 72 vs. 61, specificity: 87 vs. 92; YI: 0.60 vs.
0.53). History of ON was best predicted by a combination
of tLat and tAUC, with a clear increase in sensitivity
compared to the model with cLat and cAmp (sens: 88 vs.
77; spec: 83 vs. 85; YI: 0.71 vs. 0.62). Using only latency
as a predictor for history of ON increased specificity at the
cost of sensitivity, with tLat being superior to cLat (sens:
79 vs. 70; spec: 90 vs. 90; YI: 0.69 vs. 0.60).
Discussion
In the present study, topographic analysis of the P100
component of the VEP is compared to conventional
Table 2 Descriptors of logistic regression models on ‘‘diagnosis’’
(MS vs. HC) and ‘‘history of optic neuritis’’ for conventional (c) and
topographic (t) predictors (apR2: adjusted pseudo-R2; BIC: Bayesian
information criterion)
‘‘Diagnosis’’ ‘‘History of optic neuritis’’
apR2 BIC apR2 BIC
cLat 0.25 131 0.21 94
cLat ? cAmp 0.25 136 0.26 91
tLat 0.26 131 0.32 81
tLat ? tFit 0.28 130 0.32 85
tLat ? tAUC 0.26 134 0.35 82
tLat ? tAmp 0.26 133 0.34 83
Bold models with lowest BIC and/or highest apR2
Table 3 Comparison of sensitivity and specificity of conventional
(c) and topographic (t) measures in predicting diagnosis (MS vs. HC)
and history of optic neuritis
‘‘Diagnosis’’ ‘‘History of optic neuritis’’
Sensitivity Specificity Sensitivity Specificity
cLat 60 89 70 90
cLat ? cAmp 61 92 77 85
tLat 60 91 79 90
tLat ? tFit 72 87 79 90
tLat ? tAUC 68 89 88 83
tLat ? tAmp 75 75 84 88
Bold values at highest index of Youden (=maximal sum of sensitivity
and specificity)
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readings in a large group of well-characterized MS patients
and healthy controls. A trend for higher test–retest reli-
ability is observed for the topographic assessment of
amplitude measures in healthy controls. Diagnostic yield
for MS is higher and prediction of a history of optic neuritis
is better with the topographic method. However, the con-
ventional method performs equally well in discriminating
between the two groups and in predicting a history of optic
neuritis when the most pathological VEPs are excluded.
Thus, the advantage of topographic analysis lies in the
quantification of difficult VEPs, in which conventional
waveforms are frequently ambiguous and no conclusion
can be made. However, even in the more straightforward
cases of normally configured VEP, the fact that the topo-
graphic analysis is automatic and does not rely on sub-
jective decisions of experienced investigators can still be
an advantage.
For monitoring the disease course, the use of only the
most robust EP components has been recommended (Comi
et al. 1999) and has been found useful (Fuhr et al. 2001;
Schlaeger et al. 2012a, b, 2013). In the present study, the
P100 latency shows highest test–retest reliability in the
same range as reported previously (Meienberg et al. 1979;
Thomae et al. 2010) and is the main factor in predicting
diagnostic group and history of ON.
However, diagnostic sensitivity is increased by consid-
ering topographic fit as an additional factor. Topographic fit
represents the maximal spatial correlation of each subject’s
time series of topographic maps to the reference maps
derived from healthy controls. Low spatial correlation is
expected in asymmetries or distortion of the field distribu-
tion. In conventional recordings, marked amplitude asym-
metries between lateral recording electrodes after full-field
stimulation can be a sign of a retrochiasmal lesion (Blum-
hardt and Halliday 1978). Unfortunately, amplitude asym-
metries are quite insensitive: even in subjects with gross
hemispheric lesions and hemianopsia, amplitude asymme-
tries to full-field stimulation are still within normal limits in
45 % of patients (Blumhardt et al. 1982), as the physio-
logical variability of amplitude asymmetries is high. How-
ever, the influence of retrochiasmal lesions may be one
possible explanation for the increased diagnostic sensitivity
when topographic fit is used, because spatial correlation
does not depend on amplitudes but amplitude asymmetries
may alter the scalp field distribution of the potential.
The inclusion of amplitude measures markedly increases
the sensitivity of detection of a prechiasmal lesion defined
as a positive history of ON, with a clear advantage for
topographic measures. This observation suggests that
amplitude may carry complementary information to
latency. This suggestion is supported by the fact that in
MS, VEP amplitude but not latency is associated with
reduced thickness of the retinal nerve fibre layer and with
decreased macular volume (Trip et al. 2005), as well as
with optic nerve atrophy (Trip et al. 2006).
One reason why amplitude measures were found to be
less informative than latency in previous longitudinal
studies (Brusa et al. 1999, 2001) may be that they are less
reliable, so that statistical inferences are more difficult.
Conventional amplitude assessment depends on the P100
and N75 peaks, which may not be maximal at predefined
electrode positions in individuals. Furthermore, the N75 is
more variable than the P100 (Meienberg et al. 1979; Tho-
mae et al. 2010). One way to make amplitude measurement
more reliable is to optimize stimulation by using multifocal
VEP, in which the central and peripheral visual field are
stimulated simultaneously (Klistorner et al. 2008, Laron
et al. 2009). Using this technique, the amplitude in the non-
affected eye was shown to be lower in patients at high risk
for multiple sclerosis than in those with a low risk twelve
months after a first ON (Klistorner et al. 2009). In contrast,
amplitude measurement in topographic analysis is opti-
mized by the use of the global field power, which reflects the
field strength measured over all electrodes, and by relying
only on the P100 component, thus eliminating both elec-
trode position and the N75 as sources of variability. Com-
bining an optimized stimulation technique with an
optimized measurement technique might further reduce the
variability of the VEP amplitude. However, the potential
clinical benefit of an improved assessment of amplitude and
configuration regarding future functional impairment
remains to be determined in longitudinal studies.
In the present study, the findings of Lascano et al. (2009)
regarding the validity of topographic analysis are confirmed
and extended in a larger sample of MS patients and with a
presumably wider range of pathologic abnormalities. In both
studies, the sensitivity for a diagnosis of MS is found to be
higher for topographic than for conventional measures
(72 % vs. 60 % present study; 72 % vs. 56 % Lascano et al.
2009). Furthermore, the present study reveals an advanta-
geous high sensitivity (88 %) and specificity (83 %) of
topographic measures for the detection of clinical and sub-
clinical prechiasmal changes.
Ill-defined, pathological VEPs generally pose problems
for analysis, as the definition of the P100 component is often
ambiguous in these cases. Topographic component defini-
tion is advantageous here, as it relies on the distribution of the
electric potential on the scalp, rather than on the peak height,
and automatically determines whether a P100 component is
present. However, VEPs of eyes with visual acuity of 0.2 or
less had to be excluded from automatic component detection,
as noise can resemble a P100 field distribution in such cases.
A specific limitation of tVEP is the use of a fixed time win-
dow, which reduces the dynamic range of the method. The
use of a time window of 70–150 ms allowed the measure-
ment of values in most MS patients in the present study; still,
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6.6 % of the VEP had a peak outside this time window.
However, with a larger time window, late components with a
predominant P100 field distribution and high peaks would
have been mistaken for the P100 latency even in healthy
controls. A smaller time window (89–133 ms), as used in the
study of Lascano et al. (2009), would have further reduced
the dynamic range. In our data, 12.4 % of VEPs would have
had the peak outside the given window. However, the sig-
nificance of such a reduced dynamic range has to be deter-
mined longitudinally. A further limitation of the method is
the laborious pre-processing that it currently requires.
As neuro-degeneration in MS is only incompletely
understood and not well targeted by the available therapeutic
options, suitable biomarkers still need to be developed
(Ziemann et al. 2011). The non-systematic involvement of
different functional systems requires the combination of
different EP modalities for an adequate characterization of
the multifocal disease process. Still, each modality should
add sensitively reliable information. Thus, advanced VEP
techniques may increase the known prognostic value of
multimodal evoked potentials (Fuhr et al. 2001; Kallmann
et al. 2006; Schlaeger et al. 2012a, b, 2013). Furthermore,
cognitive symptoms may be quantified by measurement of
the P300 in oddball tasks (Whelan et al. 2010; Kiiski et al.
2011) or by measures of neuronal coordination (Leocani
et al. 2000; Tecchio et al. 2008; Hardmeier et al. 2012).
Beyond evoked potentials, combination of different methods
may turn out to be the most successful way to capture the
heterogeneity of the disease (Ziemann et al. 2011).
Conclusions
This study demonstrates the reliability, validity and sensi-
tivity of an automated detection of VEP and suggests a role
for multichannel recording and topographic analysis of the
VEP in the characterization of the disease course of MS,
which requires maximal objectivity in the assessment of as
many parameters of CNS function as possible. Longitudi-
nal studies are warranted to address this question further.
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